Voxel based analyses of diffusion tensor imaging in Fabry disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 9, 2007, Pages 964-969

  Albrecht, J ^b   Dellani, P R ^b   Muller M J ^b   Schermuly, I ^b   Beck, M ^b   Stoeter, P ^b   Gerhard, A ^b   Fellgiebel, A ^a,b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANISOTROPY; ARTICLE; BRAIN DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; FABRY DISEASE; FEMALE; GRAY MATTER; HUMAN; IMAGE PROCESSING; MALE; PRIORITY JOURNAL; PULVINAR; THALAMUS; WHITE MATTER;

ADULT; ANISOTROPY; BRAIN; CASE-CONTROL STUDIES; DIFFUSION; DIFFUSION MAGNETIC RESONANCE IMAGING; FABRY DISEASE; FEASIBILITY STUDIES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED;

EID: 34548173233     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.112987     Document Type: Article

References (38)

1. Meikle PJ, Hopwood JJ, Clague AE, et al. Prevalence of lysosomal storage disorders. JAMA 1999;281:249-54.
2. Desnick RJ IY, Eng CM. Galactosidase A deficiency: Fabry disease, 8th edn. New York: McGraw-Hill, 2001.
3. Rolfs A, Bottcher T, Zschiesche M, et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 2005;366:1794-6.
4. Mehta A, Ricci R, Widmer U, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 2004;34:236-42.
5. Moore DF, Altarescu G, Barker WC, et al. White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regions. Brain Res Bull 2003;62:231-40.
6. Fellgiebel A, Mazanek M, Whybra C, et al. Pattern of microstructural brain tissue alterations in Fabry disease: a diffusion-tensor imaging study. J Neurol 2006;253:780-7.
7. Crutchfield KE, Patronas NJ, Dambrosia JM, et al. Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurofogy 1998;50:1746-9.
8. Tedeschi G, Bonavita S, Banerjee TK, et al. Diffuse central neuronal involvement in Fabry disease: a proton MRS imaging study. Neurology 1999;52:1663-7.
9. Mitsias P, Levine SR. Cerebrovascular complications of Fabry's disease. Ann Neurol 1996;40:8-17.
10. Ginsberg L, Manara R, Valentine AR, et al. Magnetic resonance imaging changes in Fabry disease. Acta Paediatr Suppl 2006;95:57-62.
11. Fellgiebel A, Muller MJ, Mazanek M, et al. White matter lesion severity in male and female patients with Fabry disease. Neurology 2005;65:600-2.
12. Fellgiebel A, Muller MJ, Ginsberg L. CNS manifestations of Fabry's disease. Lancet Neurol 2006;5:791-5.
13. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652-9.
14. Prins ND, van Straaten EC, van Diik EJ, et al. Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology 2004;62:1533-9.
15. Nakayama N, Okumura A, Shinoda J, et al. Evidence for white matter disruption in traumatic brain injury without macroscopic lesions. J Neurol Neurosurg Psychiatry 2006;77:850-5.
16. Pfefferbaum A, Sullivan EV. Microstructural but not macrostructural disruption of white matter in women with chronic alcoholism. Neuroimage 2002;15:708-18.
17. Fellgiebel A, Wille P, Muller MJ, et al. Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study. Dement Geriatr Cogn Disord 2004;18:101-8.
18. Beaulieu C, Allen PS. Water diffusion in the giant axon of the squid: implications for diffusion-weighted MRI of the nervous system. Magn Reson Med 1994;32:579-83.
19. Le Bihan D, Mangin JF, Poupon C, et al. Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 2001;13:534-46.
20. Moore DF, Schiffmann R, Ulug AM. Elevated CNS average diffusion constant in Fabry disease. Acta Paediatr Suppl 2002;91:67-8.
21. Desnick RJ, Brady R, Barranger J, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003;138:338-46.
22. Basser PJ, Mattiello J, LeBihan D. Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B 1994;103:247-54.
23. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage 2000;11 (Pt 1):805-21.
24. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical Publishers, 1988.
25. Li X, Li L, Lu H, et al. Partial volume segmentation of brain magnetic resonance images based on maximum a posteriori probability. Med Phys 2005;32:2337-45.
26. Medina D, DeToledo-Morrell L, Urresta F, et al. White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging 2006;27:663-72.
27. Virta A, Barnett A, Pierpaoli C. Visualizing and characterizing white matter fiber structure and architecture in the human pyramidal tract using diffusion tensor MRI. Magn Reson Imaging 1999;17:1121-33.
28. Holtmannspotter M, Peters N, Opherk C, et al. Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL: a two-year follow-up study. Stroke 2005;36:2559-65.
29. O'Sullivan M, Barrick TR, Morris RG, et al. Damage within a network of white matter regions underlies executive dysfunction in CADASIL. Neurology 2005;65:1584-90.
30. Pfefferbaum A, Sullivan EV. Increased brain white matter diffusivity in normal adult aging: relationship to anisotropy and partial voluming. Magn Reson Med 2003;49:953-61.
31. Salat DH, Tuch DS, Greve DN, et al. Age-related alterations in white matter microstructure measured by diffusion tensor imaging. Neurobiol Aging 2005;26:1215-27.
32. Politei JM, Capizzano AA. Magnetic resonance image findings in 5 young patients with Fabry disease. Neurologist 2006;12:103-5.
33. Moore DF, Ye F, Schiffmann R, et al. Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease. AJNR Am J Neuroradiol 2003;24:1096-101.
34. Takanashi J, Barkovich AJ, Dillon WP, et al. T1 hyperintensity in the pulvinar: key imaging feature for diagnosis of Fabry disease. AJNR Am J Neuroradiol 2003;24:916-21.
35. Molko N, Pappata S, Mangin JF, et al. Diffusion tensor imaging study of subcortical gray matter in cadasii. Stroke 2001;32:2049-54.
36. Shibata M, Ohtani R, Ihara M, et al. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 2004;35:2598-603.
37. deVeber GA, Schwarting GA, Kolodny EH, et al. Fabry disease: immunocytochemical characterization of neuronal involvement. Ann Neurol 1992;31:409-15.
38. Kaye EM, Kolodny EH, Logigian EL, et al. Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation. Ann Neurol 1988;23:505-9.